Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fostroxacitabine bralpamide (MIV-818) is an orally active Troxacitabine-based nucleotide prodrug. Fostroxacitabine bralpamide has anticancer effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | Fostroxacitabine bralpamide (MIV-818) is an orally active Troxacitabine-based nucleotide prodrug. Fostroxacitabine bralpamide has anticancer effects. |
In vitro | Fostroxacitabine bralpamide (MIV-818) undergoes significant metabolism by human hepatocytes, resulting in elevated concentrations of the chain-terminating nucleotide tri-phosphate in the liver. This tri-phosphate incorporates into DNA during the replication process, culminating in DNA double-strand breaks, eliciting DNA damage responses, and inducing cytotoxicity[1]. |
Synonyms | MIV-818 |
Molecular Weight | 589.38 |
Formula | C22H30BrN4O8P |
CAS No. | 2129993-56-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fostroxacitabine bralpamide 2129993-56-0 MIV-818 MIV818 MIV 818 inhibitor inhibit